Anexate®

THERAPEUTIC INDICATION

Anexate^® is indicated to neutralize totally or partially the central sedative effect of benzodiazepines.
Therefore, it should be used in anesthesia and intensive care in the following indications

In anesthesia:

• To end the general anesthesia induced and maintained with benzodiazepines in hospitalized patients.
• To stop the sedation produced by benzodiazepines in patients undergoing short diagnostic or therapeutic procedures in a hospital or outpatient setting.
• To counteract the paradoxical reactions due to benzodiazepines.
• To reverse the central sedation induced by benzodiazepines in children older than 1 year.

In intensive care:

• For the diagnosis and / or maintenance of a voluntary or accidental benzodiazepine overdose.
• As a diagnostic measure in unconsciousness of unknown etiology, in order to check whether it is due to benzodiazepines, other drugs or a brain injury.
• For the specific neutralization of the central effects of benzodiazepines administered at too high doses (recovery of spontaneous respiration and consciousness in order not to have to intubate unnecessarily or to proceed with extubation).